Media Center

Background Image

Press Releases

  • Mitsubishi Tanabe Pharma Canada Announces Availability Of Radicava® (Edaravone) for Amyotrophic Lateral Sclerosis

    Mitsubishi Tanabe Pharma Canada, Inc....

    Read More
  • Update on Canada Product Availability

    Mitsubishi Tanabe Pharma Canada (MTP-CA)...

    Read More
  • Status Update on Commercial Availability of RADICAVA ™ (edaravone) in Canada

    Mitsubishi Tanabe Pharma Canada (MTP-CA)...

    Read More
  • Mitsubishi Tanabe Pharma Canada Announces Availability Of Radicava® (Edaravone) for Amyotrophic Lateral Sclerosis

    Mitsubishi Tanabe Pharma Canada, Inc....

    Read More
  • Update on Canada Product Availability

    Mitsubishi Tanabe Pharma Canada (MTP-CA)...

    Read More
  • Status Update on Commercial Availability of RADICAVA ™ (edaravone) in Canada

    Mitsubishi Tanabe Pharma Canada (MTP-CA)...

    Read More
  • New Country Manager Brings Significant Business Leadership And Healthcare Expertise to Mitsubishi Tanabe Pharma Canada, Inc.

    TORONTO, September 28, 2018 – Mitsubishi...

    Read More
  • Mitsubishi Tanabe Pharma Canada Announces Canadian Authorization of RADICAVA™ (edaravone) to Treat ALS

    Mitsubishi Tanabe Pharma Canada, Inc....

    Read More
  • Health Canada Accepts Mitsubishi Tanabe Pharma Corporation’s NDS Filing for Edaravone to Treat ALS, Grants Priority Review

    Mitsubishi Tanabe Pharma Canada Launched...

    Read More